Home/Filings/4/0001128732-21-000003
4//SEC Filing

MERZOUKI ABDERRAZZAK 4

Accession 0001128732-21-000003

CIK 0001402328other

Filed

Feb 15, 7:00 PM ET

Accepted

Feb 16, 12:36 PM ET

Size

4.7 KB

Accession

0001128732-21-000003

Insider Transaction Report

Form 4
Period: 2021-01-06
MERZOUKI ABDERRAZZAK
DirectorChief Operating Officer
Transactions
  • Award

    Common Stock

    2021-01-06$0.00/sh+20,000,000$20,00023,342,500 total

Issuer

Sunshine Biopharma, Inc

CIK 0001402328

Entity typeother

Related Parties

1
  • filerCIK 0001636418

Filing Metadata

Form type
4
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 12:36 PM ET
Size
4.7 KB